Pituitary Tumor Surveillance: Pathogenic Correlation

Part of paid clinical trials in Los Angeles, California.

Sponsor
Cedars-Sinai Medical Center
Study ID
NCT00599092
Status
Recruiting
Apply to this trial

Conditions

  • Pituitary Tumor

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.

Key Dates

Start date
Jan 31, 1997
Status verified
Mar 2026
Primary completion
Dec 31, 2050
Completion
Dec 31, 2050

Study Design

Enrollment
1,250 participants (estimated)

Primary Outcome Measure

Overall Survival (Longevity) [ Time Frame: 20 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Cedars-Sinai Medical Center, Pituitary CenterLos AngelesCalifornia90048
Daniel Gomez
[email protected]
424-315-2362
Shlomo Melmed, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By research site
Cedars-Sinai Medical Center, Pituitary Center· Los Angeles, CA

Related Studies